APA (7 वां संस्करण) प्रशस्ति पत्र

Bafadhel, M., Sing, D., Jenkins, C., Peterson, S., Bengtsson, T., & Fageras, M. (2018). Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS). European Respiratory Society.

शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र

Bafadhel, M., D. Sing, C. Jenkins, S. Peterson, T. Bengtsson, और M. Fageras. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.

एमएलए (9वां संस्करण) प्रशस्ति पत्र

Bafadhel, M., et al. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.